CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $330,000 | -1.2% | 13,312 | 0.0% | 0.01% | +8.3% |
| Q1 2022 | $334,000 | -47.6% | 13,312 | -23.9% | 0.01% | -45.5% |
| Q4 2021 | $637,000 | -77.9% | 17,492 | -89.6% | 0.02% | -82.1% |
| Q3 2021 | $2,885,000 | +21.7% | 168,733 | -4.6% | 0.12% | +24.2% |
| Q2 2021 | $2,370,000 | +527.0% | 176,900 | +2800.0% | 0.10% | +607.1% |
| Q4 2020 | $378,000 | -55.2% | 6,100 | -60.4% | 0.01% | -65.0% |
| Q3 2020 | $844,000 | -87.0% | 15,393 | -86.3% | 0.04% | -89.1% |
| Q2 2020 | $6,473,000 | – | 112,500 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |